Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Ayala Pharmaceuticals Price to Sales Ratio 2010-2023 | ADXS

Historical PS ratio values for Ayala Pharmaceuticals (ADXS) over the last 10 years. The current P/S ratio for Ayala Pharmaceuticals as of May 10, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Ayala Pharmaceuticals P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2021-12-22 0.24 1.75
2021-10-31 0.48 $0.14 3.53
2021-07-31 0.41 $0.47 0.88
2020-10-31 0.34 $0.33 1.01
2020-07-31 0.58 $0.33 1.73
2020-04-30 0.67 $0.38 1.75
2020-01-31 0.86 $16.15 0.05
2019-10-31 0.32 $355.61 0.00
2019-07-31 0.56 $356.51 0.00
2019-04-30 3.54 $356.46 0.01
2019-01-31 5.69 $366.12 0.02
2021-04-30 0.49 $68.65 0.01
2018-10-31 8.42 $127.35 0.07
2018-07-31 21.90 $127.35 0.17
2018-04-30 24.00 $191.62 0.13
2018-01-31 44.40 $251.57 0.18
2017-10-31 51.00 $193.52 0.26
2017-07-31 97.05 $307.01 0.32
2017-04-30 128.40 $216.98 0.59
2021-01-31 0.73 $115.04 0.01
2017-01-31 134.40 $113.50 1.18
2016-10-31 121.35 $8.90 13.64
2016-07-31 125.10 $8.90 14.06
2016-04-30 116.10 $8.90 13.05
2016-01-31 102.30 $8.90 11.50
2015-10-31 166.35 0 0.00
2015-07-31 249.90 0 0.00
2015-04-30 252.15 0 0.00
2015-01-31 147.75 $76.34 1.94
2014-10-31 47.70 $76.34 0.62
2014-07-31 42.60 $76.34 0.56
2014-04-30 40.80 $76.34 0.53
2014-01-31 67.35 0 0.00
2013-10-31 56.10 0 0.00
2013-07-31 52.50 0 0.00
2013-04-30 131.25 0 0.00
2013-01-31 131.25 0 0.00
2012-10-31 93.75 0 0.00
2012-07-31 131.25 0 0.00
2012-04-30 243.75 0 0.00
2012-01-31 281.25 0 0.00
2011-10-31 262.50 0 0.00
2011-07-31 281.25 0 0.00
2011-04-30 393.75 $0.00 0.00
2011-01-31 281.25 $0.00 0.00
2010-10-31 281.25 $0.00 0.00
2010-07-31 318.75 $0.00 0.00
2010-04-30 412.50 $0.00 0.00
2010-01-31 262.50 $-0.00 0.00
2009-10-31 243.75 $-0.00 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.005B $0.000B
Ayala Pharmaceuticals Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for patients suffering from rare tumors and aggressive cancers. It also involved in developing proprietary Lm-based antigen delivery products for patients suffering from more common cancers. The company's lead candidates under development are AL102 and ADXS-504. Ayala Pharmaceuticals Inc., formerly known as Advaxis Inc., is based in REHOVOT, Israel.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.132B 31.36
Chugai Pharmaceutical (CHGCY) Japan $51.893B 23.20
Takeda Pharmaceutical (TAK) Japan $41.934B 8.49
Merck (MKGAF) Germany $21.758B 20.53
Astellas Pharma (ALPMY) Japan $17.590B 27.77
Sandoz Group AG (SDZNY) Switzerland $15.507B 0.00
Shionogi (SGIOY) Japan $14.163B 12.70
Neurocrine Biosciences (NBIX) United States $13.757B 37.66
United Therapeutics (UTHR) United States $11.722B 12.50
Catalent (CTLT) United States $10.100B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.911B 7.60
Revolution Medicines (RVMD) United States $6.146B 0.00
Ionis Pharmaceuticals (IONS) United States $5.704B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.374B 0.00
Alpine Immune Sciences (ALPN) United States $4.257B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.780B 0.00
Summit Therapeutics (SMMT) United States $3.264B 0.00
Corcept Therapeutics (CORT) United States $2.815B 25.51
Arrowhead Pharmaceuticals (ARWR) United States $2.736B 0.00
PTC Therapeutics (PTCT) United States $2.473B 0.00
Indivior (INDV) United States $2.445B 11.59
Dyne Therapeutics (DYN) United States $2.272B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.045B 11.68
Recursion Pharmaceuticals (RXRX) United States $2.018B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.913B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.883B 18.32
Fusion Pharmaceuticals (FUSN) Canada $1.827B 0.00
Evotec AG (EVO) Germany $1.825B 0.00
Ardelyx (ARDX) United States $1.808B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.590B 27.83
Soleno Therapeutics (SLNO) United States $1.503B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.496B 0.00
Xencor (XNCR) United States $1.386B 0.00
Pacira BioSciences (PCRX) United States $1.369B 13.02
4D Molecular Therapeutics (FDMT) United States $1.315B 0.00
Enliven Therapeutics (ELVN) United States $1.101B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.098B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.096B 17.07
Cronos Group (CRON) Canada $1.058B 0.00
Collegium Pharmaceutical (COLL) United States $1.030B 6.16
Centessa Pharmaceuticals (CNTA) United Kingdom $0.904B 0.00
USANA Health Sciences (USNA) United States $0.890B 14.55
Ocular Therapeutix (OCUL) United States $0.877B 0.00
Cassava Sciences (SAVA) United States $0.875B 0.00
Relay Therapeutics (RLAY) United States $0.852B 0.00
ARS Pharmaceuticals (SPRY) United States $0.847B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.716B 0.00
Sage Therapeutics (SAGE) United States $0.716B 0.00
ProKidney (PROK) United States $0.644B 0.00
Savara (SVRA) United States $0.643B 0.00
Silence Therapeutics (SLN) United Kingdom $0.635B 0.00
Lyell Immunopharma (LYEL) United States $0.627B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.612B 0.00
Exscientia (EXAI) United Kingdom $0.557B 0.00
OmniAb (OABI) United States $0.548B 0.00
Siga Technologies (SIGA) United States $0.531B 6.78
Altimmune (ALT) United States $0.512B 0.00
KalVista Pharmaceuticals (KALV) United States $0.510B 0.00
Verve Therapeutics (VERV) United States $0.505B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.459B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.455B 0.00
Larimar Therapeutics (LRMR) United States $0.454B 0.00
Lexeo Therapeutics (LXEO) United States $0.433B 0.00
Bioventus (BVS) United States $0.428B 16.36
Heron Therapeutics (HRTX) United States $0.417B 0.00
Esperion Therapeutics (ESPR) United States $0.415B 0.00
Harrow (HROW) United States $0.410B 0.00
Korro Bio (KRRO) United States $0.409B 0.00
Organogenesis (ORGO) United States $0.400B 75.75
Tourmaline Bio (TRML) United States $0.372B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.339B 0.00
Nektar Therapeutics (NKTR) United States $0.323B 0.00
Black Diamond Therapeutics (BDTX) United States $0.321B 0.00
Nanobiotix S.A (NBTX) France $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.308B 19.61
Fractyl Health (GUTS) United States $0.296B 0.00
Aquestive Therapeutics (AQST) United States $0.281B 0.00
ESSA Pharma (EPIX) Canada $0.276B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.268B 0.00
Adherex Technologies (FENC) United States $0.266B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.256B 0.00
Akebia Therapeutics (AKBA) United States $0.253B 0.00
Metagenomi (MGX) United States $0.245B 0.00
Foghorn Therapeutics (FHTX) United States $0.237B 0.00
Eliem Therapeutics (ELYM) United States $0.235B 0.00
Aldeyra Therapeutics (ALDX) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.219B 0.00
Avita Medical (RCEL) United States $0.213B 0.00
Zevra Therapeutics (ZVRA) United States $0.209B 0.00
Telomir Pharmaceuticals (TELO) United States $0.205B 0.00
Century Therapeutics (IPSC) United States $0.203B 0.00
Acrivon Therapeutics (ACRV) United States $0.199B 0.00
Profound Medical (PROF) Canada $0.189B 0.00
Galectin Therapeutics (GALT) United States $0.188B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.173B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Incannex Healthcare (IXHL) Australia $0.161B 0.00
Achieve Life Sciences (ACHV) Canada $0.158B 0.00
Prelude Therapeutics (PRLD) United States $0.157B 0.00
Cardiol Therapeutics (CRDL) Canada $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.145B 13.56
Regulus Therapeutics (RGLS) United States $0.145B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
Context Therapeutics (CNTX) United States $0.140B 0.00
OptiNose (OPTN) United States $0.138B 0.00
Karyopharm Therapeutics (KPTI) United States $0.128B 0.00
VAXART, INC (VXRT) United States $0.125B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.119B 7.98
FibroGen (FGEN) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
Relmada Therapeutics (RLMD) United States $0.107B 0.00
PMV Pharmaceuticals (PMVP) United States $0.105B 0.00
Vivani Medical (VANI) United States $0.100B 0.00
Inotiv (NOTV) United States $0.097B 0.00
Assertio Holdings (ASRT) United States $0.091B 4.17
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Jaguar Animal Health (JAGX) United States $0.081B 0.00
SCYNEXIS (SCYX) United States $0.073B 1.03
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Tempest Therapeutics (TPST) United States $0.072B 0.00
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Protara Therapeutics (TARA) United States $0.062B 0.00
Carisma Therapeutics (CARM) United States $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.060B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.052B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Nutriband (NTRB) United States $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
JanOne (JAN) United States $0.036B 0.00
CASI Pharmaceuticals (CASI) China $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
DURECT (DRRX) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
Aptorum Group (APM) United Kingdom $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
PolyPid (PYPD) Israel $0.023B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.020B 0.77
Alaunos Therapeutics (TCRT) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
CERo Therapeutics Holdings (CERO) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Molecular Templates (MTEM) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Vivos Therapeutics (VVOS) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.23
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 36.98